Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$178.21 Mil
% of Total Estimate Gain
3.72%

Radcliffe Capital Management, L.P.'s Jazz Pharmaceuticals PLC Holding Summary

As of 2025-03-31, Radcliffe Capital Management, L.P. held - shares of Jazz Pharmaceuticals PLC(JAZZ), totaling N/A. This investment constitutes 0% of their stock portfolio, and Radcliffe Capital Management, L.P. now holds 0% of the outstanding Jazz Pharmaceuticals PLC(JAZZ) stock.

The initial trade took place in 2023Q1. And since then Radcliffe Capital Management, L.P. has made 4 purchases of JAZZ, at an average price of $118.13, for a total of 40.56 Mil shares. In addition, there have been 2 sales at an average price of $122.52 for 40.56 Mil shares. Based on historical transaction data and JAZZ's current price of $116.34, Radcliffe Capital Management, L.P.'s estimated gain on his JAZZ holdings is $178.21 Mil, reflecting a 3.72% gain to date.

Radcliffe Capital Management, L.P. JAZZ ($116.34) Holding Chart

Radcliffe Capital Management, L.P. JAZZ ($116.34) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1